Michelle Suter, a 63-year-old retiree from St. Louis, has experienced significant weight loss while taking the GLP-1 medication Wegovy, shedding around 28 pounds. After years of wearing loose-fitting clothes, she is beginning to envision a new wardrobe tailored to her changing size. Suter has already purchased smaller T-shirts and sneakers as she adopts a more active lifestyle.
The rise in GLP-1 drug usage among Americans is prompting fashion retailers to adapt to shifting consumer needs. Circana, a market research firm, noted a decline in sales of larger bra sizes, which serves as an indicator of broader trends in the clothing market. Retailers like Stitch Fix and Victoria’s Secret have reported an increase in customer interest related to weight loss and clothing purchases. These changes in demand are expected to positively impact various segments, with estimates suggesting GLP-1 users could drive an additional $13 billion in apparel spending annually.
About 1 in 8 U.S. adults are currently using GLP-1 medications, and projections indicate that by 2030, over 30 million Americans could be on such treatments. A recent Circana survey found that 80% of GLP-1 users expect to buy new clothing due to changes in size. As shoppers transition to smaller sizes, brands must navigate the dual challenge of appealing to newfound consumer needs while addressing the emotional and physical transformations associated with weight loss.
Key apparel beneficiaries include off-price retailers, athletic wear brands, and bespoke clothing services, all of which are poised to capitalize on this emerging market.
Why this story matters
- The trend of rising GLP-1 drug usage is reshaping consumer behavior in fashion retail.
Key takeaway
- Significant demand for new clothing is expected as GLP-1 users look to update their wardrobes due to weight loss.
Opposing viewpoint
- Some retailers may struggle to meet the diverse needs of customers in transition, as not all individuals prefer to shop for new clothes immediately after weight fluctuations.
